 "Health insurance, cashless, credit cards, loans on card swipe")
In FY24, the company reported a total revenue of Rs 14.61 crore and a profit before tax of Rs 1.28 crore. (Representational image)
Veerhealth Care on Monday said it is expecting to reach revenue of Rs 100 crore in the next 2 to 3 years.
In a statement, the company said it has executed and delivered an export order valued at $50,000 (about Rs 41.50 lakh). Additionally, another export order valued at $197,793 (approximately Rs 165 lakh) is scheduled to be fully executed and delivered by the end of July.
According to the statement, the company has also received an additional export order worth $106,673 (about Rs 89 lakh) from top US Institutional Supplier.
The order will be executed within three months, as stipulated by the terms of the purchase agreement.
Further, it stated that it is expecting monthly repeat orders from the same top US Institutional Supplier.
In addition to this, the company said it is renovating its existing plant in Vapi, Gujarat, to set up a bigger plant which will be US FDA & WHO-compliant.
In February 2024, the company has announced its expansion plans with a proposed investment of Rs 33 crore.
In FY24, the company reported a total revenue of Rs 14.61 crore and a profit before tax of Rs 1.28 crore.
Bhavin Shah, Managing Director, Veerhealth Care said, “This additional export order from a top institutional supplier in the United States is a testament to the quality and reliability of our products. It reflects the trust and satisfaction our international partners have in our capabilities.” VeerHealth Care Ltd (BSE 511523) is involved in the business of manufacturing and supply of Ayurvedic medicines, oral care products & personal care products.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
First Published: Jul 15 2024 | 12:06 PM IST
